Novartis isn't going anywhere. Heck they might even buy the company since at least we now know via biopsy that the drug works in certain categories of patients and is safe.
And 3 more trial results coming over the next 18 months.
Stock will dip and then fully recover and then some. Even the after hours volume today is stupid low, less than one days avg volume. It is the stupid money selling.
Yawn. Wish the results were better. But these were at least ok.
News 
Market Data 
Discover 
